Skip to main content
$53.75 -$0.52 (-1.0%)

04:00 PM EDT on 09/26/23

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

CAPS Rating: 3 out of 5

Current Price $53.75 Mkt Cap $5.2B
Open $53.95 P/E Ratio -27.98
Prev. Close $53.75 Div. (Yield) $0.00 (0.0%)
Daily Range $53.21 - $54.90 Volume 769,794
52-Wk Range $42.01 - $67.05 Avg. Daily Vol. 638,746

Caps

How do you think NASDAQ:ITCI will perform against the market?

Add Stock to CAPS Watchlist

All Players

43 Outperform
6 Underperform
 

All-Star Players

7 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITCI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (< 20)
Submitted February 03, 2020

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market… More

Hendrickson71 (< 20)
Submitted January 06, 2016

Come on sugar factory, come down to earth already, Let's see some $40s this week,

NASDAQ:ITCI Summary

Recent Community Commentary

Read the most recent pitches from players about ITCI.

Recs

2
Member Avatar odocoileus (< 20) Submitted: 2/2/2020 7:00:11 PM : Outperform Start Price: $12.32 NASDAQ:ITCI Score: +302.16

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market size or marketing muscle, it's a crapshoot for me whether the drug will take off. So here we are. ITCI has a new class of drug in a huge indication. I'm hanging on expecting big things. Tell me what I'm missing.

Recs

1
Member Avatar emtking (44.93) Submitted: 12/13/2019 1:05:50 PM : Outperform Start Price: $12.60 NASDAQ:ITCI Score: +293.97

New drug for bipolar disorder looks as close to a sure thing as there can be going into an FDA decision date of December 278th or sooner, 2019.

Recs

1
Member Avatar LifeScientist (< 20) Submitted: 2/17/2016 2:37:17 PM : Outperform Start Price: $30.57 NASDAQ:ITCI Score: -43.83

watch 27 is an entry

Leaderboard

Find the members with the highest scoring picks in ITCI.

Score Leader

baselineace

baselineace (< 20) Score: +371.97

Sometimes you just get lucky?

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
odocoileus < 20 12/11/2019 Outperform 5Y $12.32 +337.66% +35.50% +302.16 1 Comment
emtking 44.93 12/13/2019 Outperform 5Y $12.60 +327.94% +33.97% +293.97 1 Comment
derbydog85 56.48 12/23/2016 Outperform 5Y $15.62 +245.20% +88.64% +156.56 0 Comment
joe508mama 29.14 9/30/2016 Outperform 5Y $15.41 +249.90% +97.24% +152.67 0 Comment
warrenout 39.47 9/30/2016 Outperform 3M $15.41 +249.90% +97.24% +152.67 0 Comment
jmdor2222 82.80 9/29/2016 Outperform 5Y $15.49 +248.09% +97.36% +150.74 0 Comment
Dananator < 20 8/7/2020 Outperform 5Y $20.97 +157.19% +27.32% +129.87 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. km00nster < 20 9/21/2015 Underperform 5Y $50.63 +6.50% +117.02% +110.52 1 Comment
12x < 20 3/4/2020 Outperform 5Y $21.73 +148.14% +38.75% +109.39 0 Comment
Hendrickson71 < 20 1/7/2016 Underperform 3W $48.05 +12.22% +117.75% +105.54 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITCI.